Lactobacillus reuteri CCFM1132

N/A

Report date: 2024/01/10 17:54:26

Base Information

Drug NameLactobacillus reuteri CCFM1132
Drug Alias Name罗伊氏乳杆菌CCFM1132Lactobacillus reuteri CCFM-1132罗伊氏乳杆菌CCFM-1132
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionBacteria replacements
TargetsNot applicable
Therapy Area/IndicationsHyperuricemiaPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesJiangnan University
China Registration ClassN/A

Develop Information

Active CompaniesJiangnan University
Inactive CompaniesN/A
Active IndicationsHyperuricemiaPsoriasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A